| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 59.499 | 55.713 | 58.402 | 58.736 |
| Total Income - EUR | - | - | - | - | - | - | 59.500 | 56.223 | 60.024 | 60.173 |
| Total Expenses - EUR | - | - | - | - | - | - | 19.235 | 16.410 | 22.895 | 19.138 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 40.265 | 39.813 | 37.129 | 41.035 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 38.519 | 38.866 | 36.559 | 40.168 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oxigenium Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 6 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 40.748 | 42.004 | 40.289 | 43.883 |
| Inventories | - | - | - | - | - | - | 239 | 451 | 1.044 | 684 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 0 | 40 |
| Cash | - | - | - | - | - | - | 40.509 | 41.553 | 39.245 | 43.158 |
| Shareholders Funds | - | - | - | - | - | - | 38.721 | 39.110 | 36.801 | 40.409 |
| Social Capital | - | - | - | - | - | - | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | 2.032 | 2.895 | 3.602 | 3.550 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Oxigenium Med S.r.l.